Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial

a study on Thoracic Diseases Postoperative Pain Opioid Use

Summary

for people ages 18 years and up (full criteria)
healthy people welcome
at San Francisco, California
study started
estimated completion:
Johannes R. Kratz

Description

Summary

The Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial is a single center, double-blind, randomized, active-comparator controlled clinical trial to assess the analgesic efficacy of intercostal nerve block by Liposomal Bupivacaine versus Standard Bupivacaine in subjects undergoing lung resection by robotic or video-assisted thoracoscopic surgery.

Official Title

Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial - Liposomal Bupivacaine Versus Standard Bupivacaine

Keywords

Thoracic Diseases Postoperative Pain Opioid Use Liposomal Bupivacaine Intercostal Nerve Block Minimally Invasive Thoracic Surgery Pain, Postoperative Bupivacaine Standard Bupivacaine

Eligibility

You can join if…

Open to people ages 18 years and up

  • Robotic or Video-Assisted Lung Resection for All Indications

You CAN'T join if...

  • Additional Thoracic Procedures (beyond lung resection and mediastinal lymphadenectomy)
  • Extra-Thoracic Procedures
  • Hypersensitivity to Amide Local Analgesia
  • Cardiac Conduction Abnormalities
  • Hepatic Dysfunction
  • Preoperative Neuropathic Pain and/or Preoperative Daily Opioid Usage

Location

  • University of California, San Francisco accepting new patients
    San Francisco California 94143 United States

Lead Scientist

  • Johannes R. Kratz
    Assistant Professor, Surgery. Authored (or co-authored) 25 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT03508830
Phase
Phase 3
Study Type
Interventional
Last Updated